Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hurle

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Current Opinion in Biotechnology|August 1, 1994
Protein engineering techniques for antibody humanizationM R Hurle, M Gross
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|June 1, 1987
Mutant sequences as probes of protein folding mechanismsC R Matthews, M R Hurle
The Journal of Urology|December 22, 1999
Low dose bacillus Calmette-Guerin for carcinoma in situ of the bladder: long-term resultsA Losa, R Hurle, A Lembo
Biochimica Et Biophysica Acta|June 17, 1987
Proline isomerization and the slow folding reactions of the alpha subunit of tryptophan synthase from Escherichia coliM R Hurle, C R Matthews
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|June 1, 1995
[Our current indications for radical prostatectomy]P Graziotti, A Losa, R Hurle, et al.
British Journal of Urology|April 2, 1998
Acid-fast bacilli persisting in the genitourinary tract 3 years after intravesical bacille Calmette-Guérin therapy for bladder carcinomaR Hurle, A Losa, A Ranieri, et al.
Urology|August 12, 1999
Intravesical bacille Calmette-Guérin in Stage T1 grade 3 bladder cancer therapy: a 7-year follow-upR Hurle, A Losa, A Manzetti, et al.
Urology|June 15, 1999
Upper urinary tract tumors developing after treatment of superficial bladder cancer: 7-year follow-up of 591 consecutive patientsR Hurle, A Losa, A Manzetti, et al.
Plos Computational Biology|May 22, 2018
Systematic interrogation of diverse Omic data reveals interpretable, robust, and generalizable transcriptomic features of clinically successful therapeutic targetsAndrew D Rouillard, Mark R Hurle, Pankaj Agarwal
Protein Engineering|April 1, 1991
Confirmation of the predicted source of a slow folding reaction: proline 8 of bovine pancreatic trypsin inhibitorM R Hurle, S Anderson, I D Kuntz
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Current Opinion in Biotechnology|August 1, 1994
Protein engineering techniques for antibody humanizationM R Hurle, M Gross
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|June 1, 1987
Mutant sequences as probes of protein folding mechanismsC R Matthews, M R Hurle
The Journal of Urology|December 22, 1999
Low dose bacillus Calmette-Guerin for carcinoma in situ of the bladder: long-term resultsA Losa, R Hurle, A Lembo
Biochimica Et Biophysica Acta|June 17, 1987
Proline isomerization and the slow folding reactions of the alpha subunit of tryptophan synthase from Escherichia coliM R Hurle, C R Matthews
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|June 1, 1995
[Our current indications for radical prostatectomy]P Graziotti, A Losa, R Hurle, et al.
British Journal of Urology|April 2, 1998
Acid-fast bacilli persisting in the genitourinary tract 3 years after intravesical bacille Calmette-Guérin therapy for bladder carcinomaR Hurle, A Losa, A Ranieri, et al.
Urology|August 12, 1999
Intravesical bacille Calmette-Guérin in Stage T1 grade 3 bladder cancer therapy: a 7-year follow-upR Hurle, A Losa, A Manzetti, et al.
Urology|June 15, 1999
Upper urinary tract tumors developing after treatment of superficial bladder cancer: 7-year follow-up of 591 consecutive patientsR Hurle, A Losa, A Manzetti, et al.
Plos Computational Biology|May 22, 2018
Systematic interrogation of diverse Omic data reveals interpretable, robust, and generalizable transcriptomic features of clinically successful therapeutic targetsAndrew D Rouillard, Mark R Hurle, Pankaj Agarwal
Protein Engineering|April 1, 1991
Confirmation of the predicted source of a slow folding reaction: proline 8 of bovine pancreatic trypsin inhibitorM R Hurle, S Anderson, I D Kuntz
Pageof 6